{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:07:09Z","timestamp":1794607629275,"version":"4.9.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.antiviral.2007.10.009","type":"journal-article","created":{"date-parts":[[2007,12,5]],"date-time":"2007-12-05T14:48:26Z","timestamp":1196866106000},"page":"116-124","source":"Crossref","is-referenced-by-count":178,"title":["Treatment of yellow fever"],"prefix":"10.1016","volume":"78","author":[{"given":"Thomas P.","family":"Monath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2007.10.009_bib1","first-page":"647","article-title":"Effect of human gamma interferon on yellow fever virus infection","volume":"38","author":"Arroyo","year":"1989","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2007.10.009_bib2","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Barba-Spaeth","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2007.10.009_bib3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(04)17017-7","article-title":"History of thymoma and yellow fever vaccination","volume":"364","author":"Barwick","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2007.10.009_bib4","doi-asserted-by":"crossref","first-page":"12883","DOI":"10.1074\/jbc.M611318200","article-title":"Functional characterization of cis and trans activity of the Flavivirus NS2B-NS3 protease","volume":"282","author":"Bera","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2007.10.009_bib5","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0611681104","article-title":"c-Src protein kinase inhibitors block assembly and maturation of dengue virus","volume":"104","author":"Chu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. (USA)"},{"key":"10.1016\/j.antiviral.2007.10.009_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1086\/344180","article-title":"A Belgian traveller who acquired yellow fever in the Gambia","volume":"35","author":"Colebunders","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.009_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2006.02.005","article-title":"Yellow fever vaccine-associated viscerotropic disease and death in Spain","volume":"36","author":"Doblas","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2007.10.009_bib8","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.antiviral.2007.10.009_bib9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/AAC.19.6.1042","article-title":"Plasma disappearance, urine excretion, and tissue distribution of ribavirin in rats and rhesus monkeys","volume":"19","author":"Ferrara","year":"1981","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.10.009_bib10","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1021\/np50089a003","article-title":"Antiviral (RNA) activity of selected Amaryllidaceae isoquinolone constituents and synthesis of related substances","volume":"55","author":"Gabrielsen","year":"1992","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.antiviral.2007.10.009_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/095632029400500402","article-title":"In vitro and in vivo antiviral (RNA) evaluation of orotidine 5\u2032-monophosphate decarboxylase inhibitors and analagoues including 6-azauridine-5\u2032-(ethyl methoxyalaniyl)phosphate (a 5\u2032-monopjhosphate prodrug)","volume":"5","author":"Gabrielsen","year":"1994","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2007.10.009_bib12","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1021\/jm051229y","article-title":"Identification of compounds with anti-West Nile virus activity","volume":"49","author":"Goodell","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2007.10.009_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/095632020701800105","article-title":"Antiviral profiles of novel iminocyclitol compounds against bovine viral diarrhea virus, West Nile virus, dengue virus and hepatitis B virus","volume":"18","author":"Gu","year":"2007","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2007.10.009_bib14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.trstmh.2007.06.013","article-title":"Acute viscerotropic disease following vaccination against yellow fever","volume":"101","author":"Hayes","year":"2007","journal-title":"Trans. Roy. Soc. Trop. Med. Hyg."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2007.10.009_bib15","doi-asserted-by":"crossref","first-page":"S750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","article-title":"Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug","volume":"11","author":"Huggins","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.009_bib16","series-title":"Clinical Applications of Ribavirin","first-page":"49","article-title":"Efficacy of ribavirin and tributylribavirin against virulent RNA infections","author":"Huggins","year":"1984"},{"key":"10.1016\/j.antiviral.2007.10.009_bib17","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1128\/AAC.01494-06","article-title":"Activity of T-1106 in a hamster model of yellow fever virus infection","volume":"51","author":"Julander","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.10.009_bib18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.antiviral.2006.08.008","article-title":"Comparison of the inhibitory effects of interferon alfacon-1 and ribavirin on yellow fever virus infection in a hamster model","volume":"73","author":"Julander","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2007.10.009_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nm1245","article-title":"Reversing systemic inflammatory response syndrome with chemokine receptor pepducins","volume":"11","author":"Kaneider","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2007.10.009_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/0470058005.ch8","article-title":"Finding new medicines for flaviviral targets","volume":"277","author":"Keller","year":"2006","journal-title":"Novartis Found Symp."},{"key":"10.1016\/j.antiviral.2007.10.009_bib21","first-page":"51","article-title":"Treatment of experimental viral infections with immunomodulators","volume":"68","author":"Kende","year":"1988","journal-title":"Adv. Biosci."},{"key":"10.1016\/j.antiviral.2007.10.009_bib22","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2007.10.009_bib23","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1021\/jm0607606","article-title":"Peptide inhibitors of West Nile NS3 protease: SAR study of tetrapeptide aldehyde inhibitors","volume":"49","author":"Knox","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2007.10.009_bib24","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.micinf.2006.01.013","article-title":"Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection","volume":"8","author":"Lefeuvre","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.antiviral.2007.10.009_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.virusres.2007.03.022","article-title":"Functional determinants of NS2B for activation of Japanese encephalitis virus NS3 protease","volume":"127","author":"Lin","year":"2007","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2007.10.009_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0166-3542(90)90029-7","article-title":"Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys","volume":"13","author":"Malinoski","year":"1990","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2007.10.009_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJM198601023140104","article-title":"Lassa fever. Effective therapy with ribavirin","volume":"314","author":"McCormick","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2007.10.009_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/9.1.165","article-title":"Yellow fever: a medically neglected disease. Report on a seminar","volume":"9","author":"Monath","year":"1987","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.009_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0065-3527(03)60009-6","article-title":"Pathogenesis and pathophysiology of yellow fever","volume":"60","author":"Monath","year":"2003","journal-title":"Adv. Virus Dis."},{"key":"10.1016\/j.antiviral.2007.10.009_bib30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4269\/ajtmh.1981.30.431","article-title":"Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues","volume":"30","author":"Monath","year":"1981","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2007.10.009_bib31","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant vaccine against West Nile virus","volume":"103","author":"Monath","year":"2006","journal-title":"Proc. Natl. Acad. Sci. (USA)"},{"key":"10.1016\/j.antiviral.2007.10.009_bib32","doi-asserted-by":"crossref","unstructured":"Monath, T.P., Cetron, M.S., Teuwen, D.E., 2008. Yellow fever, in: Plotkin S, Orenstein W (Eds.), Vaccines, 5th ed., Saunders, Philadelphia, in press.","DOI":"10.1016\/B978-1-4160-3611-1.50040-4"},{"key":"10.1016\/j.antiviral.2007.10.009_bib33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.antiviral.2005.06.002","article-title":"Broad-spectrum inhibitor of viruses in the Flaviviridae family","volume":"68","author":"Ojwang","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2007.10.009_bib34","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1128\/JVI.02830-06","article-title":"Identification of residues critical for the interferon antagonist function of Langat virus NS5 reveals a role for the RNA-dependent RNA polymerase domain","volume":"81","author":"Park","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.009_bib35","first-page":"522","article-title":"Rapport sur la valeur immunisante des vaccins employes contre la fievre jaune et la valeur therapeutique du serum antiamaril","volume":"105","author":"Pettit","year":"1931","journal-title":"Bull. Acad. Nat. Med."},{"key":"10.1016\/j.antiviral.2007.10.009_bib36","first-page":"541","article-title":"Serum anti-amaryllique","volume":"99","author":"Pettit","year":"1928","journal-title":"Compt. Rend. Soc. Biol."},{"key":"10.1016\/j.antiviral.2007.10.009_bib37","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1600-0854.2007.00579.x","article-title":"Nuclear localization of dengue virus nonstructural protein 5 through its importin alpha\/beta-recognized nuclear localization sequences is integral to viral infection","volume":"8","author":"Pryor","year":"2007","journal-title":"Traffic"},{"key":"10.1016\/j.antiviral.2007.10.009_bib38","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.50.4.1320-1329.2006","article-title":"Triaryl pyrazoline compound inhibits flavivirus RNA replication","volume":"50","author":"Puig-Basaqoiti","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2007.10.009_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2005.08.019","article-title":"Immunohistochemical examination of the role of Fas ligand and lymphocytes in the pathogenesis of human liver yellow fever","volume":"116","author":"Quaresma","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2007.10.009_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.trstmh.2006.02.019","article-title":"Hepatocyte lesions and cellular immune response in yellow fever infection","volume":"101","author":"Quaresma","year":"2007","journal-title":"Trans. Roy. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2007.10.009_bib41","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2007.10.009_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/clpt.1987.165","article-title":"Ribavirin pharmacodynamics in high-risk patients for acquired immunodeficiency syndrome","volume":"42","author":"Roberts","year":"1987","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2007.10.009_bib43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4269\/ajtmh.2004.71.306","article-title":"Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease","volume":"71","author":"Sbrana","year":"2004","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2007.10.009_bib44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/136.1.122","article-title":"Effect of a nuclease\u2013resistant derivative of polyriboinosinic\u2013polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta)","volume":"136","author":"Stephen","year":"1977","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.009_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.mvr.2006.08.002","article-title":"Neutrophil-activating activity and platelet-activating factor synthesis in cytokine-stimulated endothelial cells: reduced activity in growth-arrested cells","volume":"73","author":"Takahashi","year":"2007","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.antiviral.2007.10.009_bib46","first-page":"260","volume":"12","author":"Tam","year":"2003","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.antiviral.2007.10.009_bib47","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1086\/425016","article-title":"Activation of the cytokine network and unfavorable outcome in patients with yellow fever","volume":"190","author":"ter Meulen","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.009_bib48","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/320199","article-title":"Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies","volume":"183","author":"Tesh","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.009_bib49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.2164-0947.1960.tb00696.x","article-title":"Experimental yellow fever","volume":"22","author":"Tigertt","year":"1960","journal-title":"Trans. N. Y. Acad. Sci."},{"key":"10.1016\/j.antiviral.2007.10.009_bib50","first-page":"246","author":"US Army Medical Research Institute of Infectious Diseases","year":"1972","journal-title":"Annu. Rep."},{"key":"10.1016\/j.antiviral.2007.10.009_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4269\/ajtmh.2006.75.333","article-title":"Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996\u20132004","volume":"75","author":"Vellozzi","year":"2006","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2007.10.009_bib52","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1128\/JVI.79.16.10268-10277.2005","article-title":"Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing","volume":"79","author":"Wu","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.009_bib53","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1086\/320200","article-title":"Experimental yellow fever virus infection in the Golden hamster (Mesocricetus auratus). II. Pathology","volume":"183","author":"Xiao","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2007.10.009_bib54","doi-asserted-by":"crossref","first-page":"10278","DOI":"10.1128\/JVI.79.16.10278-10288.2005","article-title":"Structure of the Dengue virus helicase\/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A","volume":"79","author":"Xu","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.009_bib55","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1128\/JVI.02283-06","article-title":"Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution","volume":"81","author":"Yap","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2007.10.009_bib56","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jpba.2006.09.001","article-title":"LC\u2013MS\/MS method for simultaneous determination of viramidine and ribavirin levels in monkey red blood cells","volume":"43","author":"Yeh","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.antiviral.2007.10.009_bib57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.bmcl.2005.09.062","article-title":"Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead","volume":"16","author":"Yin","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2007.10.009_bib58","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bmcl.2005.09.049","article-title":"Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors","volume":"16","author":"Yin","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207004329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354207004329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,29]],"date-time":"2021-08-29T22:37:07Z","timestamp":1630276627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354207004329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0166354207004329"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2007.10.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}